We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

1 hedge funds and large institutions have $2.35K invested in iTeos Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

98.8% less ownership

Funds ownership: 98.8% → 0% (-99%)

99% less funds holding

Funds holding: 136 → 1 (-135)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $377M → $2.35K (-$377M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 135

Holders
1
Holders Change
-135
Holders Change %
-99.26%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
135
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$20

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$107M
2
BlackRock
BlackRock
New York
-$45.6M
3
TCM
Tang Capital Management
California
-$38.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$16.6M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$8.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$114K -11,466 Closed
AIM
102
Aigen Investment Management
New York
– -$113K -11,291 Closed
QCM
103
Quantinno Capital Management
New York
– -$103K -10,305 Closed
VIA
104
Virtus Investment Advisers
Connecticut
– -$93.9K -9,422 Closed
CUAMC
105
China Universal Asset Management Company
China
– -$76.6K -7,687 Closed
SO
106
STRS Ohio
Ohio
– -$70.8K -7,100 Closed
BNP Paribas Financial Markets
107
BNP Paribas Financial Markets
France
– -$68.4K -6,864 Closed
PFSRSONJ
108
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$52K -5,213 Closed
New York State Common Retirement Fund
109
New York State Common Retirement Fund
New York
– -$50.9K -5,109 Closed
TRCT
110
Tower Research Capital (TRC)
New York
– -$39.4K -3,953 Closed
Legal & General Group
111
Legal & General Group
United Kingdom
– -$27.1K -2,717 Closed
AIP
112
Ameritas Investment Partners
Nebraska
– -$24.4K -2,444 Closed
Russell Investments Group
113
Russell Investments Group
United Kingdom
– -$23.2K -2,328 Closed
California State Teachers Retirement System (CalSTRS)
114
California State Teachers Retirement System (CalSTRS)
California
– -$19.6K -1,967 Closed
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
– -$19.3K -1,939 Closed
PNC Financial Services Group
116
PNC Financial Services Group
Pennsylvania
– -$15.3K -1,537 Closed
Mirae Asset Global Investments
117
Mirae Asset Global Investments
South Korea
– -$14.7K -1,479 Closed
CIAM
118
Caitong International Asset Management
Hong Kong
– -$10.7K -1,073 Closed
GFM
119
GF Fund Management
China
– -$9.32K -935 Closed
AB
120
Amalgamated Bank
New York
– -$8K -825 Closed
SCM
121
Sterling Capital Management
North Carolina
– -$7.5K -752 Closed
EWA
122
EverSource Wealth Advisors
Alabama
– -$6.34K -636 Closed
BIG
123
Brooklyn Investment Group
New York
– -$5.54K -556 Closed
EP
124
Essential Partners
California
– -$3.77K -378 Closed
US Bancorp
125
US Bancorp
Minnesota
– -$1.49K -149 Closed
2 3 4
5
6

ITOS Hedge Fund Activity: Q3 2025 in Review

1 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q3 2025, worth a combined $2.35K — down 100% from $377M a quarter earlier.

Sellers outnumbered buyers: 135 funds closed out of ITOS and 0 opened new positions — a net loss of 135 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was IFP Advisors, adding an estimated $20. The largest seller was EcoR1 Capital, exiting entirely with an estimated $107M sold.

  • 1 institutional investor held iTeos Therapeutics (ITOS) as of Q3 2025, down from 136 in Q2 2025.
  • Funds reported $2.35K of iTeos Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new iTeos Therapeutics positions in Q3 2025 and 135 closed out, a net change of -135 holders.
  • The largest iTeos Therapeutics buyer in Q3 2025 was IFP Advisors, an estimated $20 added.
  • The largest iTeos Therapeutics seller in Q3 2025 was EcoR1 Capital, an estimated $107M sold.

Based on aggregated 13F filings for Q3 2025.